Comparative SPECT findings of Tc-99m depreotide, Tc-99m tetrofosmin, and Tl-201 chloride for bronchogenic carcinoma.
Nuclear Medicine Service, Lexington VA Medical Center and Department of Internal Medicine, University of Kentucky Medical Center, Lexington, Kentucky 40511, USA. Weh-Jen.Shih@med.va.gov
Wei-Jen
WJ
Shih
Eric S
ES
Bensadoun
Edward
E
Hirschowitz
Vickie
V
Kieffer
Kelly
K
Gross
D001707:Biopsy, Needle; D002283:Carcinoma, Bronchogenic / Q000000981:diagnostic imaging* / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000000981:diagnostic imaging / Q000473:pathology; D005188:False Negative Reactions; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009943:Organophosphorus Compounds; D015609:Organotechnetium Compounds; D011859:Radiography; D019275:Radiopharmaceuticals; D013004:Somatostatin / Q000031:analogs & derivatives*; D013793:Thallium; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods
D009943:Organophosphorus Compounds; D015609:Organotechnetium Compounds; D019275:Radiopharmaceuticals; C027549:thallium chloride; C078700:technetium tc-99m tetrofosmin; D013004:Somatostatin; C444119:technetium Tc 99m depreotide; D013793:Thallium